Innovation Spirits
We have independently developed 10 minimally invasive interventional treatment solutions targeting tricuspid valve diseases, mitral valve diseases, aortic valve diseases, and heart failure. All products are based on our original innovation and possess global patents and independent intellectual property rights.

Our self-developed transcatheter mitral valve replacement system, JensRelive, is designed for the treatment of patients with severe mitral regurgitation and can replace dysfunctional primary mitral valves without undergoing routine thoracotomy surgery. JensRelive consists of an artificial mitral valve, a delivery catheter system, and a loading system. JensRelive adopts a unique anchoring design that helps secure while preventing displacement. In addition, JensRelive also has both recyclable and adjustable bending functions, which is expected to improve the accuracy and stability of valve positioning during placement.